Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signalling regulatory protein expression by water extracts of I'm-Yunity™ (PSP)

被引:51
作者
Hsieh T.-C. [1 ]
Wu P. [1 ]
Park S. [1 ]
Wu J.M. [1 ]
机构
[1] Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla
来源
BMC Complementary and Alternative Medicine | / 6卷 / 1期
关键词
Aqueous Extract; Water Extract; COX2 Expression; Edible Mushroom; Mushroom Product;
D O I
10.1186/1472-6882-6-30
中图分类号
学科分类号
摘要
Background: I'm-Yunity™ (PSP) is a mushroom extract derived from deep-layer cultivated mycelia of the patented Cov-I strain of Coriolus versicolor (CV), which contains as its main bioactive ingredient a family of polysaccharo-peptide with heterogeneous charge properties and molecular sizes. I'm-Yunity™ (PSP) is used as a dietary supplement by cancer patients and by individuals diagnosed with various chronic diseases. Laboratory studies have shown that I'm-Yunity™ (PSP) enhances immune functions and also modulates cellular responses to external challenges. Recently, I'm-Yunity™ (PSP) was also reported to exert potent anti-tumorigenic effects, evident by suppression of cell proliferation and induction of apoptosis in malignant cells. We investigate the mechanisms by which I'm-Yunity™ (PSP) elicits these effects. Methods: Human leukemia HL-60 and U-937 cells were incubated with increasing doses of aqueous extracts of I'm-Yunity™ (PSP). Control and treated cells were harvested at various times and analyzed for changes in: (1) cell proliferation and viability, (2) cell cycle phase transition, (3) induction of apoptosis, (4) expression of cell cycle, apoptogenic/anti-apoptotic, and extracellular regulatory proteins. Results: Aqueous extracts of I'm-Yunity™ (PSP) inhibited cell proliferation and induced apoptosis in HL-60 and U-937 cells, accompanied by a cell type-dependent. disruption of the G1/S and G2/M phases of cell cycle progression. A more pronounced growth suppression was observed in treated HL-60 cells, which was correlated with time- and dose-dependent down regulation of the retinoblastoma protein Rb, diminution in the expression of anti-apoptotic proteins bcl-2 and survivin, increase in apoptogenic proteins bax and cytochrome c, and cleavage of poly(ADP-ribose) polymerase (PARP) from its native I 12-kDa form to the 89-kDa truncated product. Moreover, I'm-Yunity™ (PSP)-treated HL-60 cells also showed a substantial decrease in p65 and to a lesser degree p50 forms of transcription factor NF-κB, which was accompanied by a reduction in the expression of cyclooxygenase 2 (COX2). I'm-Yunity™ (PSP) also elicited an increase in STATI (signal transducer and activator of transcription) and correspondingly, decrease in the expression of activated form of ERK (extracellular signal-regulated kinase). Conclusion: Aqueous extracts of I'm-Yunity™ (PSP) induces cell cycle arrest and alterations in the expression of apoptogenic/anti-apoptotic and extracellular signaling regulatory proteins in human leukemia cells, the net result being suppression of proliferation and increase in apoptosis. These findings may contribute to the reported clinical and overall health effects of I'm-Yunity™ (PSP). © 2006 Hsieh et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 107 条
[1]
Yang M.M., Chen Z., Kwok J.S., The anti-tumor effect of a small polypeptide from Coriolus versicolor (SPCV), Am J Chin Med, 20, pp. 221-232, (1992)
[2]
Wasser S.P., Weis A.L., Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective, Crit Rev Immunol, 19, pp. 65-96, (1999)
[3]
Borchers A.T., Stern J.S., Hackman R.M., Keen C.L., Gershwin M.E., Mushrooms, tumors, and immunity, Proc Soc Exp Biol Med, 221, pp. 281-293, (1999)
[4]
Kidd P.M., The use of mushroom glucans and proteoglycans in cancer treatment, Altern Med Rev, 5, pp. 4-27, (2000)
[5]
Hsieh T.C., Wu J.M., Cell growth and gene modulatory activities of Yunzhi (Windsor Wunxi) from mushroom Trametes versicolor in androgen-dependent and androgen-insensitive human prostate cancer cells, Int J Oncol, 18, pp. 81-88, (2001)
[6]
Chu K.K., Ho S.S., Chow A.H., Coriolus versicolor: A medicinal mushroom with promising immunotherapeutic values, J Clin Pharmacol, 42, pp. 976-984, (2002)
[7]
Chang R., Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants, J Altern Complement Med, 8, pp. 559-565, (2002)
[8]
Chang R., White J.D., Asian therapies for cancer - Coming of age, J Altern Complement Med, 8, pp. 541-543, (2002)
[9]
Zaidman B.Z., Yassin M., Mahajna J., Wasser S.P., Medicinal mushroom modulators of molecular targets as cancer therapeutics, Appl Microbiol Biotechnol, 67, pp. 453-468, (2005)
[10]
Fullerton S.A., Samadi A.A., Tortorelis D.G., Choudhury M.S., Mallouh C., Tazaki H., Konno S., Induction of apoptosis in human prostatic cancer cells with beta-glucan (Maitake mushroom polysaccharide), Mol Urol, 4, pp. 7-13, (2000)